Explaining end-users' intentions to use innovative medical and food biotechnology products

Bob C. Mulder, P. Marijn P.M. Poortvliet, Peter Lugtig, Marijn De Bruin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people's tendency (or lack thereof) to be innovative.
Original languageEnglish
Pages (from-to)997-999
Number of pages3
JournalBiotechnology Journal
Volume9
Issue number8
Early online date12 Jun 2014
DOIs
Publication statusPublished - Aug 2014

Fingerprint

Genetically Modified Food
Biotechnology
Communicable Diseases
Vaccination
Theoretical Models
Communication
Food
Social Norms

Cite this

Explaining end-users' intentions to use innovative medical and food biotechnology products. / Mulder, Bob C.; Poortvliet, P. Marijn P.M.; Lugtig, Peter; De Bruin, Marijn.

In: Biotechnology Journal, Vol. 9, No. 8, 08.2014, p. 997-999.

Research output: Contribution to journalArticle

Mulder, Bob C. ; Poortvliet, P. Marijn P.M. ; Lugtig, Peter ; De Bruin, Marijn. / Explaining end-users' intentions to use innovative medical and food biotechnology products. In: Biotechnology Journal. 2014 ; Vol. 9, No. 8. pp. 997-999.
@article{d3042af2c787439eb41565731baa74bb,
title = "Explaining end-users' intentions to use innovative medical and food biotechnology products",
abstract = "Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people's tendency (or lack thereof) to be innovative.",
author = "Mulder, {Bob C.} and Poortvliet, {P. Marijn P.M.} and Peter Lugtig and {De Bruin}, Marijn",
year = "2014",
month = "8",
doi = "10.1002/biot.201400224",
language = "English",
volume = "9",
pages = "997--999",
journal = "Biotechnology Journal",
issn = "1860-6768",
publisher = "Wiley",
number = "8",

}

TY - JOUR

T1 - Explaining end-users' intentions to use innovative medical and food biotechnology products

AU - Mulder, Bob C.

AU - Poortvliet, P. Marijn P.M.

AU - Lugtig, Peter

AU - De Bruin, Marijn

PY - 2014/8

Y1 - 2014/8

N2 - Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people's tendency (or lack thereof) to be innovative.

AB - Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people's tendency (or lack thereof) to be innovative.

UR - http://www.scopus.com/inward/record.url?scp=84905366272&partnerID=8YFLogxK

U2 - 10.1002/biot.201400224

DO - 10.1002/biot.201400224

M3 - Article

VL - 9

SP - 997

EP - 999

JO - Biotechnology Journal

JF - Biotechnology Journal

SN - 1860-6768

IS - 8

ER -